AUVEN THERAPEUTICS
Sun Pharma completes acquisition of Ocular Technologies SarlAll the necessary formalities for closure of the said transaction have been concluded and the company has successfully completed the acquis...
Sun Pharma to buy Ocular Technologies from Auven TherapeuticsSun will pay Auven $40 million upfront, contingent development milestones and sales milestones, in addition to royalties on sales of Secier...
Fifteen stocks in focus on Thursday, 27 October 2016The Indian market is expected to open lower. Here is a list of top fifteen stocks that are likely to be in focus today.
- Load More